We are live on
!
Find out more
SC
Stralem & Co Portfolio holdings
AUM
$157M
1-Year Est. Return
4.29%
This Fund
S&P 500
This Quarter
Est. Return
+2.55%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$915M
AUM Growth
-$73.4M
(-7.4%)
Cap. Flow
-$89.1M
Cap. Flow
% of AUM
-9.75%
Top 10 Holdings %
Top 10 Hldgs %
33.03%
Holding
55
New
–
Increased
1
Reduced
49
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$63.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$4.59M |
| 2 |
AT&T
T
|
+$4.05M |
| 3 |
Coca-Cola
KO
|
+$3.61M |
| 4 |
Dominion Energy
D
|
+$3.31M |
| 5 |
Starbucks
SBUX
|
+$3.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.76% |
| 2 | Utilities | 10.08% |
| 3 | Energy | 9.92% |
| 4 | Consumer Staples | 9.73% |
| 5 | Communication Services | 8.98% |
Similar funds
LI
BC
JT
SCM
HF
SMFS
CCM
CCM
Stralem & Co's Q1 2016 Portfolio in Review
As of Q1 2016, Stralem & Co held 55 positions worth $915M, down 7.4% from $988M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Stralem & Co withdrew a net $89.1M in Q1 2016, closing 2 positions and reducing 49 holdings. Its most notable exit was NextEra Energy, an estimated $390K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Utilities and Energy.
Against the trend, Stralem & Co added an estimated $63.1K to Gilead Sciences.
- Stralem & Co added most to Gilead Sciences in Q1 2016, an estimated $63.1K increase.
- Stralem & Co's biggest Q1 2016 reduction was PPL Corp, cutting an estimated $4.59M.
- Stralem & Co fully exited NextEra Energy in Q1 2016, selling an estimated $390K.
- Stralem & Co's ten largest holdings make up 33% of its $915M portfolio in Q1 2016.
- Stralem & Co opened 0 new positions and closed 2 in Q1 2016.
- Stralem & Co's portfolio value fell 7.4% quarter-over-quarter to $915M.
Based on Stralem & Co's 13F filing for Q1 2016, filed 18 Apr 2016.